Xtandi 40 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DB25FPRN3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,509
Award facts
- Contract value 100% obligated
- $12,508.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,508.77 by the Defense Logistics Agency on September 19, 2025, for the supply of Xtandi 40 mg tablets (120-unit quantity). This firm fixed-price delivery order, which is scheduled for completion by September 22, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The award carries no set-aside designation, allowing the company to compete directly in the federal marketplace leveraging its woman-owned small business status. The contract will be performed at the company's location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's $500 million SPE2DB Indefinite Delivery Contract with the Defense Logistics Agency, which remains valid through November 2026. The broader IDC enables the DLA to issue firm fixed-price orders for a comprehensive range of pharmaceutical products, including branded and generic prescription medications, biologics, and medical consumables to support the medical supply requirements of Department of Defense healthcare facilities worldwide. Xtandi, an oncology treatment, exemplifies the company's role as a critical supplier of specialty pharmaceutical products within the federal pharmaceutical supply chain serving military health system needs.
Quick answers
Who was awarded contract SPE2DB25FPRN3?
SPE2DB25FPRN3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FPRN3 worth?
The government has obligated $12,509 on SPE2DB25FPRN3.
Is contract SPE2DB25FPRN3 an order under another contract?
Yes. SPE2DB25FPRN3 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPRN3 competed?
The extent of competition for SPE2DB25FPRN3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award